2001
DOI: 10.1634/theoncologist.6-2-162
|View full text |Cite
|
Sign up to set email alerts
|

Hepatotoxicity of Chemotherapy

Abstract: After assessment of tumor histology, the next important factor to consider in the selection of a chemotherapy regime is organ function. Patients who are to receive chemotherapy require careful assessment of liver function prior to treatment to determine which drugs may not be appropriate, and which drug doses should be modified. Following therapy abnormalities of liver function tests may be due to the therapy rather than to progressive disease, and this distinction is of critical importance. Furthermore, not a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

11
289
0
12

Year Published

2010
2010
2019
2019

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 384 publications
(312 citation statements)
references
References 148 publications
(113 reference statements)
11
289
0
12
Order By: Relevance
“…Also, we found that the CYP-immunosuppressed rats showed significant decrease in γ-globulins levels, these findings are parallel to the results observed by [13]. This may be due to the toxic effects of various chemotherapeutic on the liver, including cyclophosphamide, which was found to inhibit selected hepatic enzymes as described by [33]. CYP exerts a specific and not directly toxic effect on the cytochrome P450 system, which converts cyclophosphamide to active metabolites.…”
Section: Discussionsupporting
confidence: 87%
“…Also, we found that the CYP-immunosuppressed rats showed significant decrease in γ-globulins levels, these findings are parallel to the results observed by [13]. This may be due to the toxic effects of various chemotherapeutic on the liver, including cyclophosphamide, which was found to inhibit selected hepatic enzymes as described by [33]. CYP exerts a specific and not directly toxic effect on the cytochrome P450 system, which converts cyclophosphamide to active metabolites.…”
Section: Discussionsupporting
confidence: 87%
“…Histological changes including liver congestion, disorganization of hepatic cords and ballooning degeneration could be observed in H&E slides. At the same time we have found a remarkable decrease in body weight gain after mice being treated with CTX, notably in high dose group, implying that hepatotoxicity might have contributed to this weight loss as previously reported (King and Perry, 2001;Basu et al, 2014). In addition, we also discovered that the expression level of apoptosis-related protein caspase-3 increased in the liver of mice after received CTX.…”
Section: Discussionsupporting
confidence: 86%
“…Serum total bilirubin was estimated following the method of King and Coxon [17]. In brief, 1 ml of serum was mixed with 0.5 ml of diazo reagent, followed by 0.5 ml (NH4)2SO4.…”
Section: Total Bilirubin (Tb)mentioning
confidence: 99%